WHI, WHI, WHI?

Climacteric

Volumn 7, Issue 3, 2004, Pages 221-224

  MacLennan, Alastair H ^a   Sturdee, David W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ESTROGEN; ESTROGEN RECEPTOR; PLACEBO; PROGESTERONE;

ADULT; AGED; BREAST CANCER; CARDIOVASCULAR RISK; CLIMACTERIUM; DEMENTIA; DRUG SAFETY; EDITORIAL; ESTROGEN THERAPY; FEMALE; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; STROKE;

AGED; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; RISK FACTORS; WOMEN'S HEALTH;

EID: 4944225932     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130400001331     Document Type: Editorial

References (10)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial. J Am Med Assoc 2002;288:321-33
2. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. J Am Med Assoc 2004;291:1701-12
3. Gambrell RD. The Women's Health Initiative Reports in perspective: facts or fallacies. Climacteric 2004;7:225-8
4. Neves-e-Castro M. My dream. Climacteric 2004;7:322-3
5. Maclennan AH, Sturdee DW. Time for new long-term trials of postmenopausal hormone therapies! Climacteric 2003;6:265-7
6. The Writing Group of the IMS Executive Committee. Guidelines for the hormone treatment of women in the menopausal transition and beyond. Climacteric 2004;7:8-11
7. Genazzani AR, Gambacciani M, Simoncini T, Schneider HPG. Hormone replacement therapy in climacteric and aging brain. Climacteric 2003;6:188-203
8. Koh KK. Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy? Int J Cardiol 2003;87:1-8
9. Million Women Collaborators. Breast cancer and hormone replacement in the Million Women Study. Lancet 2003;362:419-27
10. Sturdee DW, MacLennan AH. Should epidemiology, the media and quangos determine clinical practice? Climacteric 2004;7:1-2